We must protect public health
On a recent visit to Mumbai, Dr Ian Hudson, CEO, Medicines and Healthcare products Regulatory Agency (MHRA) spoke with Viveka…
Author
Express Pharma honours FR&D leaders and gamechangers
Celebrate and laud 16 professionals for their pivotal roles towards advancements in formulation development and drug delivery
Will NDA-2’s first budget be any different for the pharma sector?
With actual fiscal outcomes for FY19 falling short of the revenue estimates put out in the interim budget, FM Sitharaman will have…
A silver lining to withdrawal of GSP benefits?
Will US President Trump’s mission to Make America Great Again turn out to be a great fillip for PM Modi’s Make in India campaign?…
FDD Leaders Handbook 2019
INDIA'S GOT FDD TALENT!
Express Pharma is honoured to present the third edition of the FDD Leaders Handbook. This continues…
‘Interactive anti-bribery training is an essential element in building a culture of compliance’
The pharmaceutical sector has seen some high profile investigations and settlements concerning bribes given to healthcare…
Own up, course correct and move on
Rather than living in denial and shooting the messenger (Eban in this case), pharma companies have to own up to their mistakes,…
Post USTR Special 301 Report, pragmatism wins over confrontation?
While both governments continue the dialogue, there are various groups working to find a middle path
‘Interactive anti-bribery training is an essential element in building a culture of compliance’
The pharmaceutical sector has seen some high profile investigations and settlements concerning bribes given to healthcare…
India on USTR’s Priority ~ Watch List again
Will we be safeguarding our national health priorities and standards if we toe the USTR’s line or get a better rank on the GIPC IP…